专利检索 ipc:C07D231/12 第 4 页

31.

发明公开
1-(2-(ETHYLSULFONYL)-PHENYL)-4-(PHENYL)-1H-1,2,3-TRIAZOLE AND 4-(2-(ETHYLSULFONYL)-PHENYL)-1-(PHENYL)-1H-1,2,3-TRIAZOLE AND RELATED COMPOUNDS DERIVATIVES AS PESTICIDES 审中-公开

公开(公告)号：EP3805213A3

公开(公告)日：2021-06-09

申请号：EP20210246.3

申请日：2016-06-17

申请人： Nippon Soda Co., Ltd.

发明人： AOYAMA, Hikaru , MATSUI, Maki , SAKANISHI, Keita , IWASA, Takao , KOBAYASHI, Tomomi , HIRATA, Koichi

IPC分类号： C07D401/14 , C07D401/04 , C07D403/04 , C07D231/12 , C07D231/14 , C07D231/16 , C07D231/38 , C07D231/40 , C07D249/06 , C07D513/04 , A01N43/56 , A01N43/647 , A01N43/653 , A01N43/90 , A01N47/18 , A01P7/02 , A01P7/04

摘要： The present invention provides a compound represented by formula (I), (in the formula, A 1 and A 2 each independently represents a carbon atom or a nitrogen atom; X 1 represents an unsubstituted or substituted C1-6 alkyl group or the like; n represents an integer of 0 to 4; R 1 represents an unsubstituted or substituted C1-6 alkylthio group or the like; B 1 and B 4 each independently represent a carbon atom, a nitrogen atom or the like; R 2 and R 3 each independently represent a hydrogen atom, a halogeno group or the like; Ar represents an unsubstituted or substituted C6-10 aryl group or the like) or a salt thereof, and a harful organism control agent including thereof.

32.

发明授权
ANDROGEN RECEPTOR MODULATING COMPOUNDS 有权

公开(公告)号：EP3369732B1

公开(公告)日：2021-05-26

申请号：EP18163765.3

申请日：2010-10-27

发明人： WOHLFAHRT, Gerd , TÖRMÄKANGAS, Olli , KARJALAINEN, Arja , KNUUTTILA, Pia , HOLM, Patrik , RASKU, Sirpa , VESALAINEN, Anniina , SALO, Harri , HÖGLUND, Lisa

IPC分类号： C07D403/12 , C07D401/14 , C07D405/14 , C07D413/14 , C07D401/12 , C07D231/12 , C07D471/12 , C07D487/04 , C07D513/04

33.

发明公开
7-HETEROCYCLYL SUBSTITUTED SANCYCLINE DERIVATIVES FOR TREATING BACTERIAL, VIRAL AND PARASITIC INFECTIONS (E.G. MALARIA) OR INFLAMMATORY DISEASES 审中-公开

公开(公告)号：EP3812372A2

公开(公告)日：2021-04-28

申请号：EP20198210.5

申请日：2007-12-21

申请人： Paratek Pharmaceuticals, Inc.

发明人： BERNIAC, Joel , VERMA, Atul K.

IPC分类号： C07D207/50 , C07D231/12 , C07D239/20 , C07D241/12 , C07D261/02 , C07D261/04 , C07D263/32 , C07D265/02 , C07C237/26 , A61K31/65 , A61P31/00 , A61P31/04 , A61P31/12 , A61P33/00 , A61P33/06

摘要： The present invention relates to tetracycline derivatives, and in particular to sancycline derivatives substituted at their 7-position by a five-membered heterocyclic ring, for use in the treatment of bacterial, viral and/or parasitic infections, such as e.g. malaria, and/or inflammatory diseases.

34.

发明公开
PYRAZOLE-AMIDE COMPOUND AND MEDICINAL USES THEREFOR 审中-公开

公开(公告)号：EP3805205A1

公开(公告)日：2021-04-14

申请号：EP20204677.7

申请日：2014-03-14

申请人： Japan Tobacco Inc.

发明人： MOTOMURA, Takahisa , SHOMI, Gakujun

IPC分类号： C07D231/12 , A61K31/415 , A61P3/00 , A61P3/04 , A61P3/10 , A61P9/04 , A61P9/10 , A61P11/00 , A61P13/12 , A61P25/00 , A61P27/02 , A61P27/12 , A61P43/00

摘要： The present invention relates to a combination drug comprising (a) compound represented by the formula [I]:

wherein n is 1 or 2, or a pharmaceutically acceptable salt thereof; and
(b) at least one other medicament effective for the prophylaxis or treatment of a disease selected from the group consisting of diabetes such as (i) type 1 diabetes or (ii) type 2 diabetes, insulin resistance syndrome, metabolic syndrome, hyperglycemia, hyperlactacidemia, diabetic complications such as (i) diabetic neuropathy, (ii) diabetic retinopathy, (iii) diabetic nephropathy or (iii) cataract, cardiac failure such as (i)acute cardiac failure or (ii) chronic cardiac failure, cardiomyopathy, myocardial ischemia, myocardial infarction, angina pectoris, dyslipidemia, atherosclerosis, peripheral arterial disease, intermittent claudication, chronic obstructive pulmonary disease, brain ischemia, cerebral apoplexy, mitochondrial disease, mitochondrial encephalomyopathy, cancer, pulmonary hypertension and Alzheimer disease, wherein the medicament (b) is/are administered simultaneously, separately or continuously.